PDB 编号 标题 Rg (Å) Dmax (Å) 实验方法 质量评级
2gx5 N-terminal GAF domain of transcriptional pleiotropic repressor CodY 33.1 101.0 X-RAY DIFFRACTION GOOD
2gx6 Rational stabilization of E. coli ribose binding protein 19.9 65.2 X-RAY DIFFRACTION GOOD
2gx8 The Crystal Structure of Bacillus cereus protein related to NIF3 36.6 104.8 X-RAY DIFFRACTION GOOD
2gx9 X-ray structure of influenza virus NS1 effector domain 21.2 68.7 X-RAY DIFFRACTION GOOD
2gxa Crystal structure of papillomavirus E1 hexameric helicase with ssDNA and MgADP 47.2 153.1 X-RAY DIFFRACTION GOOD
2gxb Crystal Structure of The Za Domain bound to Z-RNA 18.7 71.1 X-RAY DIFFRACTION GOOD
2gxf X-Ray Crystal Structure of Protein YybH from Bacillus subtilis. Northeast Structural Genomics Consortium Target SR506. 26.5 82.3 X-RAY DIFFRACTION EXCELLENT
2gxg Crystal structure of EmrR homolog from hyperthermophilic archaea Sulfolobus tokodaii strain7 19.0 64.5 X-RAY DIFFRACTION REASONABLE
2gxq HERA N-terminal domain in complex with AMP, crystal form 1 17.3 51.9 X-RAY DIFFRACTION REASONABLE
2gxs HERA N-terminal domain in complex with AMP, crystal form 2 25.4 87.2 X-RAY DIFFRACTION GOOD
2gxu HERA N-terminal domain in complex with orthophosphate, crystal form 1 17.4 52.7 X-RAY DIFFRACTION GOOD
2gy5 Tie2 Ligand-Binding Domain Crystal Structure 24.4 89.0 X-RAY DIFFRACTION GOOD
2gy7 Angiopoietin-2/Tie2 Complex Crystal Structure 33.7 117.2 X-RAY DIFFRACTION GOOD
2gyd Complex of equine apoferritin with the H-diaziflurane photolabeling reagent 19.2 68.5 X-RAY DIFFRACTION GOOD
2gyi ;DESIGN, SYNTHESIS, AND CHARACTERIZATION OF A POTENT XYLOSE ISOMERASE INHIBITOR, D-THREONOHYDROXAMIC ACID, AND HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHIC STRUCTURE OF THE ENZYME-INHIBITOR COMPLEX ; 31.1 97.9 X-RAY DIFFRACTION GOOD
2gyk Crystal structure of the complex of the Colicin E9 DNase domain with a mutant immunity protein, IMME9 (D51A) 47.2 154.8 X-RAY DIFFRACTION REASONABLE
2gyo Methanethiol-Cys 112 Inhibition Complex of E. Coli Ketoacyl Synthase III (FabH) and Coenzyme A 25.1 79.2 X-RAY DIFFRACTION GOOD
2gyp Diabetes mellitus due to a frustrated Schellman motif in HNF-1a 17.5 58.1 X-RAY DIFFRACTION REASONABLE
2gyq YcfI, a putative structural protein from Rhodopseudomonas palustris. 20.4 65.8 X-RAY DIFFRACTION REASONABLE
2gyr Crystal structure of human artemin 33.6 107.5 X-RAY DIFFRACTION REASONABLE
2gys 2.7 A structure of the extracellular domains of the human beta common receptor involved in IL-3, IL-5, and GM-CSF signalling 45.6 134.8 X-RAY DIFFRACTION GOOD
2gyt Solution structure of the SAM (sterile alpha motif) domain of DLC1 (deleted in liver cancer 1) 14.0 57.9 SOLUTION NMR REASONABLE
2gyu Crystal structure of Mus musculus Acetylcholinesterase in complex with HI-6 37.8 133.0 X-RAY DIFFRACTION GOOD
2gyv Crystal structure of Mus musculus Acetylcholinesterase in complex with Ortho-7 37.0 129.7 X-RAY DIFFRACTION GOOD
2gyw Crystal Structure of Mus musculus Acetylcholinesterase in Complex with Obidoxime 37.9 133.3 X-RAY DIFFRACTION GOOD
2gyx Crystal structure of DB884- D(CGCGAATTCGCG)2 complex at 1.86 A resolution. 13.6 46.5 X-RAY DIFFRACTION GOOD
2gyy Structure of aspartate semialdehyde dehydrogenase (ASADH) from Streptococcus pneumoniae 38.3 122.5 X-RAY DIFFRACTION EXCELLENT
2gyz Crystal structure of human artemin 19.2 66.7 X-RAY DIFFRACTION GOOD
2gz1 Structure of Aspartate Semialdehyde Dehydrogenase (ASADH) from Streptococcus pneumoniae complexed with NADP 27.8 94.6 X-RAY DIFFRACTION GOOD
2gz2 ;Structure of Aspartate Semialdehyde Dehydrogenase (ASADH) from Streptococcus pneumoniae complexed with 2',5'-ADP ; 28.0 95.7 X-RAY DIFFRACTION GOOD
2gz3 ;Structure of Aspartate Semialdehyde Dehydrogenase (ASADH) from Streptococcus pneumoniae complexed with NADP and aspartate-semialdehyde ; 38.2 118.4 X-RAY DIFFRACTION EXCELLENT
2gz4 1.5 A Crystal Structure of a Protein of Unknown Function ATU1052 from Agrobacterium tumefaciens 30.0 92.0 X-RAY DIFFRACTION EXCELLENT
2gz5 Human Type 1 methionine aminopeptidase in complex with ovalicin at 1.1 Ang 19.1 58.5 X-RAY DIFFRACTION GOOD
2gz6 Crystal Structure Of Anabaena sp. CH1 N-acetyl-D-glucosamine 2-epimerase At 2.0 A 29.7 97.3 X-RAY DIFFRACTION GOOD
2gz7 Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease 22.7 79.0 X-RAY DIFFRACTION GOOD
2gz8 Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease 22.7 79.1 X-RAY DIFFRACTION GOOD
2gz9 Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease 22.8 78.9 X-RAY DIFFRACTION REASONABLE
2gza Crystal structure of the VirB11 ATPase from the Brucella Suis type IV secretion system in complex with sulphate 33.9 112.4 X-RAY DIFFRACTION GOOD
2gzb Bauhinia bauhinioides cruzipain inhibitor (BbCI) 23.9 78.4 X-RAY DIFFRACTION GOOD
2gzd Crystal Structure of Rab11 in Complex with Rab11-FIP2 26.9 84.7 X-RAY DIFFRACTION GOOD
2gze Crystal structure of the E9 DNase domain with a mutant immunity protein IM9 (Y55A) 19.7 67.3 X-RAY DIFFRACTION REASONABLE
2gzf Crystal structure of the E9 DNase domain with a mutant immunity protein IM9 (Y54F) 19.4 64.5 X-RAY DIFFRACTION GOOD
2gzg Crystal Structure of the E9 DNase Domain with a Mutant Immunity Protein IM9 (Y55F) 19.7 64.5 X-RAY DIFFRACTION GOOD
2gzh Crystal Structure of Rab11 in Complex with Rab11-Family Interacting Protein 2 21.1 79.4 X-RAY DIFFRACTION GOOD
2gzi Crystal Structure of the E9 DNase Domain with a Mutant Immunity Protein IM9 (V34A) 19.7 65.4 X-RAY DIFFRACTION GOOD
2gzj Crystal Structure of the E9 DNase Domain with a Mutant Immunity Protein IM9 (D51A) 47.2 154.8 X-RAY DIFFRACTION REASONABLE
2gzk Structure of a complex of tandem HMG boxes and DNA 21.3 80.2 SOLUTION NMR GOOD
2gzl Structure of 2C-methyl-D-erythritol 2,4-clycodiphosphate synthase complexed with a CDP derived fluorescent inhibitor 16.4 53.7 X-RAY DIFFRACTION REASONABLE
2gzm Crystal Structure of the Glutamate Racemase from Bacillus anthracis 38.2 132.9 X-RAY DIFFRACTION GOOD
2gzo NMR structure of UPF0301 PROTEIN SO3346 from Shewanella oneidensis: Northeast Structural Genomics Consortium target SOR39 18.5 73.7 SOLUTION NMR REASONABLE